Also trades as: HAVN.CN (CNQ) · $vol 0M

$0.00

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $2565 mcap · 23M float · 0.088% daily turnover · Short 52% of daily vol

Revenue

$276K +0.0% ▲

Gross Profit

$90K +101.9% ▲

Operating Income

-$10M +67.7% ▲

Net Income

-$22M +26.1% ▲

EPS (Diluted)

$-5.25 +38.0% ▲

EBITDA

-$7M +49.5% ▲

View Full Income Statement

Line Item	FY2020	FY2021	FY2022
Revenue	$0	$0	$276K
YoY Growth	+0.0%	+0.0%	+0.0%
Cost of Revenue	$0	$5M	$187K
Gross Profit	$0	-$5M	$90K
Gross Margin	—	—	32.4%
R&D Expenses	$0	$333K	$656K
SG&A Expenses	$41K	$19M	$9M
Operating Expenses	$41K	$24M	$10M
Operating Income	-$41K	-$30M	-$10M
Operating Margin	—	—	-3548.4%
Interest Expense	$0	$17K	$64K
Income Before Tax	-$41K	-$30M	-$22M
Tax Expense	-$206K	$0	$0
Net Income	-$41K	-$30M	-$22M
Net Margin	—	—	-8117.8%
EPS (Diluted)	$-0.02	$-8.47	$-5.25
EBITDA	$0	-$15M	-$7M
Shares Outstanding	2M	4M	4M

Line Item	FY2021 Q4	FY2022 Q1	FY2022 Q2	FY2022 Q3	FY2022 Q4	FY2023 Q1	FY2023 Q2	FY2023 Q3
Revenue	$0	$9K	$28K	$23K	$216K	$68K	$315K	-$12K
Cost of Revenue	$3M	$5K	$16K	$17K	$148K	$46K	$113K	$71K
Gross Profit	-$3M	$4K	$12K	$6K	$68K	$22K	$202K	-$83K
Gross Margin	—	43.1%	42.3%	25.4%	31.5%	32.4%	64.1%	690.9%
R&D Expenses	$102K	$253K	$138K	$134K	$131K	$144K	$169K	$56K
SG&A Expenses	$8M	$3M	$3M	$2M	$1M	$784K	$770K	$611K
Operating Expenses	$10M	$3M	$3M	$2M	$2M	$974K	$940K	$667K
Operating Income	-$16M	-$3M	-$3M	-$2M	$1M	-$952K	-$1M	-$750K
Operating Margin	—	-31666.2%	-11347.1%	-8742.5%	552.4%	-1401.4%	-397.6%	6222.1%
Interest Expense	$0	$17K	$16K	$16K	$15K	$14K	$0	$2
Income Before Tax	-$11M	-$3M	-$6M	-$2M	-$11M	-$4M	-$2M	-$692K
Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$11M	-$3M	-$6M	-$2M	-$11M	-$4M	-$2M	-$692K
Net Margin	—	-31719.8%	-21360.8%	-9504.8%	-5253.1%	-5747.4%	-787.5%	5734.1%
EPS (Diluted)	$-3.07	$-22.63	$-1.42	$-0.52	$-2.38	$-27.05	$-0.41	$-0.07
EBITDA	-$14M	-$3M	-$6M	-$2M	-$11M	-$906K	-$603K	-$691K
Shares Outstanding	4M	131297	4M	4M	5M	144266	6M	10M

HAVLF OTC